New Drug Promising for Resistant Focal Epilepsy
A novel investigational antiseizure medication reduces seizure frequency by more than 50% in some patients with treatment-resistant focal epilepsy.
Stay updated with breaking news from Biomedical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A novel investigational antiseizure medication reduces seizure frequency by more than 50% in some patients with treatment-resistant focal epilepsy.
Explore the future of AI in software dev. Learn how developers can adapt, the role of AI agents like Pixie, and how to leverage AI for human ingenuity.
Charles River Laboratories International beat Wall Street estimates for second-quarter results on Wednesday.
The approval follows a series of market withdrawals for other multiple myeloma drugs that initially received accelerated FDA approval.
Emergent BioSolutions on Tuesday decided to cut 400 jobs, pivoting its focus on core products such as overdose reversal nasal spray Narcan and anthrax vaccines.